A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: HER-2 Positive Breast Cancer
Interventions: DRUG: Everolimus|DRUG: Vinorelbine|DRUG: Trastuzumab
Sponsor: UNC Lineberger Comprehensive Cancer Center
Collaborators: Novartis Pharmaceuticals